Abstracting and Indexing
Web Site of Urooncology Association
E-ISSN: 2667-4610
About US
Aims and Scope
Editorial Board
Instructions to Authors
Instructions to Authors
Ethical Policy
Contact Us
Editorial
1
Review
14
Editorial
Editorial
Güven Aslan
Full Text
Review
The developments in paradigm of prostate cancer in recent years
Sertaç Yazıcı
Halil Kızılöz
Haluk Özen
Quick View
Full Text
An update on palliative therapy in advanced prostate cancer
Kaan Özdedeli
Uğur Kuyumcuoğlu
Quick View
Full Text
Prostate cancer, screening and diagnosis according to EAU and AUA 2013 updates and practical considerations
Tünkut Doğanca
Can Öbek
Quick View
Full Text
The role of surgery for high-risk prostate cancer
Oktay Üçer
Talha Müezzinoğlu
Quick View
Full Text
Lympadenectomy in prostate cancer
Murat Koşan
Quick View
Full Text
Comparing outcomes of external radiotherapy modalities for prostate cancer
Şefik İğdem
Quick View
Full Text
In which fields intermittent androgen deprivation therapy can be used in 2014?
Yasin Ceylan
Bu¨lent Gu¨nlu¨soy
Quick View
Full Text
Open surgery is still gold standard for radical prostatectomy
Polat Türker
Levent Türkeri
Quick View
Full Text
Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer
Tayyar Alp Özkan
Özdal Dillioğlugil
Quick View
Full Text
Positron emission tomogrphy in prostate carcinoma
Recep Bekiş
Quick View
Full Text
The role of 5α-reductase inhibitors on prevention and hormonal treatment of prostate cancer
Bülent Öztürk
Tufan Çiçek
Quick View
Full Text
The influence of age on localized prostate cancer: Surgical result of patients over 70 years
Erdal Benli
Ali Ayyıldız
Quick View
Full Text
Outstanding variations in the treatment of prostate cancer bone metastases
İbrahim Cüreklibatır
Quick View
Full Text
How affected Active Surveillance the quality of life in low-risk localized prostate cancer?
İlker Çelen
Sinharib Çitgez
Talha Müezzinoğlu
Quick View
Full Text
Reviewers
Review
Article
Reviewer
Corner
Authors
Submit
Article
Author
Corner
Journal Metrics
Clarivate Current Impact Factor: 0.1
Clarivate 5 Year Impact Factor: 0.1
Journal Information
Date of Foundation
Mar 2002
Abbreviation
Bull Urooncol
Last Issue
Editorial Board
Abstract in Index
Journal History
Forms
Permission Request Form
Copyright Agreement Form
Acknowledgements Form
Useful Links
ICMJE Recommendations
Crossref Similarity Check
ICMJE Conflict of Interest Disclosure Form
EndNote